Latest Thrombolysis Stories
By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly used clot-busting technique.
ESCAPE, EXTEND IA show treatment allows more patients to live independently, return to everyday life WASHINGTON, Feb.
THR-18 significantly decreases the occurrence of intracranial hemorrhage and brain edema, and enhances recovery in acute ischemic stroke patients REHOVOT, Israel, December 18, 2014 /PRNewswire/
KALAMAZOO, Mich., Dec.
Study is most significant stroke treatment clinical trial since NINDS-2 says Society of NeuroInterventional Surgery WASHINGTON, Dec.
KALAMAZOO, Mich., Nov. 6, 2014 /PRNewswire/ -- Stryker Corporation's Trevo® ProVue Retriever has received the Prix Galien USA 2014 Award for Best Medical Technology.
Initial data show that THR-18 significantly decreases the occurrence of intracranial hemorrhage (ICH) and brain edema in acute ischemic stroke (AIS) patients REHOVOT, Israel, November 4, 2014
Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness.
At the California Institute for Deep Venous Thrombosis, Dr.
In an analysis that included data from 16 trials performed over the last 45 years, among patients with pulmonary embolism, receipt of therapy to dissolve the blood clot (thrombolysis) was associated with lower rates of death, but increased risks of major bleeding and intracranial hemorrhage.
- The governor of a province or people.